Basic Colcrys Information

• INN (International Nonproprietary Name): Colchicine; known as colchicina (Italian/Spanish) and colchicin (German/French).
• Brand Names Available In Canada (English): Marketed in Canada as colchicine (generic) with tablet, capsule and oral solution formulations similar to those available in the United States and the United Kingdom.
• ATC Code: M04AC01 — Musculo-skeletal system; Antigout preparations; Preparations with no uric acid effect; Colchicine.
• Forms & Dosages: Tablet 0.6 mg (examples: Colcrys, Lodoco); Capsule 0.6 mg (example: Mitigare); Oral solution 0.6 mg/5 mL (example: Gloperba).
• Manufacturers In Canada (English): Global suppliers include URL Pharma (Colcrys), Hikma, Prasco and multiple generic manufacturers; Canadian-specific manufacturers not specified in the source data.
• Registration Status In Canada (English): Colchicine is approved for use in Canada; products marketed domestically carry Health Canada authorisations when supplied with a Drug Identification Number.
• OTC / Rx Classification: Prescription only (Rx) in Canada and other regulated markets.

Availability & Price Landscape

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Where can patients pick up colchicine in Canada when they have a prescription?

Most Canadians with a prescription obtain colchicine from community pharmacy chains such as Shoppers Drug Mart, Rexall and London Drugs.

In Quebec, Jean Coutu is commonly used by local patients for prescription collection.

Hospital outpatient pharmacies and some community health centres also dispense colchicine, especially for specialists and chronic care patients.

Pharmacists frequently substitute generic colchicine tablets for branded products unless the prescriber writes "do not substitute".

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

How are online pharmacies changing access to colchicine?

Online Canadian pharmacies are increasing in number and offer convenience for repeat prescriptions and home delivery.

Patients should confirm a Canadian pharmacy licence and provincial pharmacy licence and seek verified pharmacist counselling before ordering online.

Cross-border purchases from U.S. suppliers remain common for brands like Colcrys or Gloperba, but these carry customs, DIN and safety risks.

Provincial formularies such as Ontario Drug Benefit, BC PharmaCare and RAMQ determine coverage and special-authority requirements for colchicine, and rules vary by indication and patient group.

In our online pharmacy, colcrys is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Price Ranges By Package Size (With Provincial Differences)

What should patients expect to pay for colchicine in Canada?

• Price depends on brand versus generic, package size and whether provincial coverage applies.
• Per-tablet pricing is lower for larger bottles and generic supplies purchased in-store or from accredited Canadian online pharmacies.
• When covered by provincial formularies (for example for FMF or eligible seniors), patient cost may be reduced or require special-authority paperwork.

Typical public-plan rules and pharmacy pricing vary by province, so patients should request a price breakdown per bottle and per tablet from their pharmacist when comparing in-store versus online offers.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Where do Canadian patients talk about colchicine?

Discussions appear on Reddit Canada, HealthBoards, AskDocs and provincial patient forums, plus pharmacy review pages and community support groups.

These platforms are commonly used for sharing dosing tips, side-effect experiences and access challenges.

Reported Benefits And Challenges From Canadian Patients

What do Canadians report about using colchicine?

Many patients report rapid reduction in gout flare pain when colchicine is taken early in the attack.

Patients with Familial Mediterranean Fever describe effective long-term control at low doses when adherence is consistent.

Common complaints include gastrointestinal side effects such as diarrhoea and nausea that limit tolerability for some users.

Access issues reported include prescription wait times, prior authorisations for provincial plans and variability in pharmacist substitution between branded and generic colchicine.

• Common patient concerns: cost, GI side effects, coordination with prescribers, and interaction checks with other medicines.
• Typical forum-reported outcomes: early dosing reduces pain, dose adjustments help elderly relatives, and pharmacist counselling improves safety.

Product Overview & Brand Variants

INN And Brand Names Used In Canada

What names might colchicine appear under in Canada?

The International Nonproprietary Name is colchicine and it is typically sold in Canada as generic colchicine products.

U.S. brand names referenced in source data include Colcrys (0.6 mg purple tablet debossed “AR 374”), Mitigare (capsule), Gloperba (oral solution) and Lodoco (cardiovascular formulation).

In Canada and the UK, colchicine is usually marketed as generic colchicine in tablet, capsule or solution form with 0.6 mg tablets being the most common strength.

Legal Classification Under Health Canada

Is colchicine prescription or over the counter in Canada?

Colchicine is classified as prescription-only (Rx) across regulated markets including Canada.

Products sold domestically must be authorised by Health Canada and normally carry a Drug Identification Number when supplied through Canadian channels.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

What are the Health Canada–approved uses of colchicine?

Health Canada–aligned indications include treatment of acute gout flares, prophylaxis of gout flares and management of Familial Mediterranean Fever (FMF).

Products supplied in Canada carry DINs to indicate Health Canada authorisation and product monographs describe dosing and approved indications for prescribers and pharmacists.

Off-Label Patterns In Canadian Healthcare

When do Canadian clinicians use colchicine off-label?

Off-label use in Canada occurs for some inflammatory conditions such as pericarditis and select dermatological disorders when clinicians provide rationale and monitoring plans.

Low-dose colchicine for cardiovascular secondary prevention is discussed internationally and used in some markets, but local use depends on regulatory status and formulary decisions.

• Approved: Acute gout flare, gout prophylaxis, FMF.
• Common off‑label uses: Pericarditis, select inflammatory conditions under specialist care.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

How does colchicine stop a gout flare?

Colchicine reduces inflammation by interfering with the movement and activation of white blood cells called neutrophils that drive the flare process.

That effect short-circuits the chain of events that causes swelling and pain during an acute gout attack.

Clinical Detail From Health Canada Resources

What is the scientific mechanism behind colchicine?

Colchicine binds to tubulin and disrupts microtubule formation, which reduces neutrophil chemotaxis and inflammasome activation.

These molecular actions translate to decreased inflammation and symptom relief.

Colchicine has a narrow therapeutic index and notable interactions via CYP3A4 and P‑glycoprotein pathways, which are clinically important for safety monitoring.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

What dosing should patients expect for gout and FMF?

For an acute gout flare, recommended regimens include 1.2 mg at onset followed by 0.6 mg one hour later, keeping label limits in mind.

Prophylaxis for gout is commonly 0.6 mg once or twice daily depending on tolerability and prescriber guidance.

For Familial Mediterranean Fever, adult dosing typically ranges 1.2–2.4 mg per day in divided doses, while children aged four years and older start at 0.6–1.2 mg/day and titrate to effect.

Adjustments By Patient Type (With Canadian Clinical Notes)

Who needs a lower dose or special monitoring?

Patients with moderate-to-severe renal or hepatic impairment require dose reduction or avoidance; colchicine is contraindicated in severe impairment or dialysis according to product information.

Elderly patients should start at a lower dose and be monitored for toxicity.

Avoid or reduce colchicine when combined with strong CYP3A4 or P‑gp inhibitors because of the risk of severe toxicity.

• Missed dose: take when remembered unless close to next dose; do not double up.
• Overdose: seek immediate medical attention because toxicity can be life‑threatening.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Who should not take colchicine or expect common effects?

Absolute contraindications include hypersensitivity to colchicine and use in severe renal or hepatic impairment, particularly when combined with strong P‑gp or CYP3A4 inhibitors.

Common side effects are dose-related gastrointestinal symptoms such as diarrhoea, nausea, vomiting and abdominal pain that often limit tolerability.

Other frequently reported effects include fatigue, myalgia and headache.

Rare But Serious (With Canadian Pharmacovigilance Data)

What rare severe problems have been reported?

Rare but serious adverse events include bone marrow suppression (pancytopenia), neuromyopathy and multi-organ failure in the context of overdose or significant drug interactions.

Patients on prolonged therapy should have clinical monitoring and blood work if clinically indicated, and anyone with severe GI symptoms, muscle weakness or infections should seek urgent medical review.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

What other medicines are used for gout or related conditions?

Note: DIN numbers for specific products should be checked in the Health Canada database or provincial formulary listings for exact product references.

Pros And Cons List

• Colchicine: Fast anti-inflammatory effect for gout flares, but narrow therapeutic index and GI side effects.
• NSAIDs: Widely available and effective, but contraindicated in renal impairment and peptic ulcer disease.
• Corticosteroids: Effective short-term but systemic side effects with repeated courses.
• Urate-Lowering Agents: Prevent future flares but do not treat acute attacks.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

What recent research should Canadian prescribers know about?

Interest in low-dose colchicine for cardiovascular secondary prevention has continued with trials and meta-analyses through 2022–2025, prompting clinical discussion about off-label low-dose regimens.

Colchicine was also evaluated during the COVID-19 period for its anti-inflammatory properties in small trials and systematic reviews.

Canadian centres have contributed observational safety data focusing on drug interactions and renal dosing in routine care.

Clinicians should consult updated systematic reviews, Health Canada advisories and peer-reviewed trial reports when considering evolving evidence for new uses.

Common Patient Questions In Canada

Do I need a prescription?

Yes, colchicine is prescription-only in Canada and should be used under medical supervision.

Will provincial drug plans cover it?

Coverage varies by province and indication; seniors and social assistance recipients may be covered under plans like Ontario Drug Benefit, BC PharmaCare or RAMQ with possible special-authority requirements.

Can I take it with my heart medication or antifungal?

Strong CYP3A4 or P‑gp inhibitors such as certain macrolide antibiotics and azole antifungals increase the risk of colchicine toxicity; review all medicines with a pharmacist before starting colchicine.

What if I get diarrhoea?

Mild diarrhoea is common and dose-related; consult a pharmacist for dose adjustment and seek medical review for severe or persistent symptoms.

Is it safe in pregnancy or breastfeeding?

Discuss use with a prescriber and specialist input may be required for pregnancy or breastfeeding decisions.

• Checklist for pharmacy visits: bring full medication list, ask for the DIN, request pharmacist counselling, and plan for baseline labs if on long-term therapy.

Regulatory Status

Health Canada Approval Process

How does Health Canada regulate colchicine?

Medicines sold domestically must be approved by Health Canada and are assigned a Drug Identification Number that links to the product monograph describing approved indications, dosing and safety information.

Colchicine products marketed in Canada carry DINs when authorised and are prescription-only.

DIN Number Relevance

Why is the DIN important for patients?

The DIN provides a reliable way to verify the authorised product, its formulation and approved uses via Health Canada’s database.

Adverse events are reported to Health Canada and provincial pharmacovigilance systems, which support post-market safety communications.

Visual Recommendations

Infographic Ideas For Canadian Context

Which visuals help patients understand colchicine?

• A dosage quick-chart showing indication, starter dose and maximum per day emphasising the common 0.6 mg tablet strength.
• An interaction matrix showing colchicine versus common CYP3A4/P‑gp inhibitors such as macrolides, azoles and some statins.
• Storage visuals showing 20–25°C (68–77°F) guidance and packaging photos to help identify legitimate tablets; for reference, Colcrys is a purple tablet debossed “AR 374” in U.S. supply.
• A provincial coverage map indicating where public plans commonly require special-authority for colchicine.

Make infographics accessible with large fonts, high contrast and clear icons for prescription, interaction warnings and pharmacist counselling.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

How should patients decide where to buy colchicine?

Purchase from licensed Canadian pharmacies that provide pharmacist counselling and verify the product’s DIN and monograph.

Be cautious with cross-border and international suppliers and check authenticity and customs rules before ordering.

Compare in-store versus online pricing while factoring in shipping, pharmacist consultation and provincial drug plan reimbursement.

Proper Storage With Canadian Climate Considerations

How should colchicine be stored at home in Canada?

Store colchicine at 20–25°C (68–77°F) with brief excursions permitted to 15–30°C and keep it in original packaging protected from moisture.

Do not freeze oral solutions and avoid leaving tablets in vehicles or in areas exposed to extreme heat or cold during Canadian summers or winters.

• Travel tip: keep colchicine in original packaging and carry a copy of your prescription.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

What steps ensure safe colchicine use in clinical practice?

Confirm the indication and obtain baseline labs such as renal and hepatic function tests and a CBC before starting chronic colchicine therapy.

Review the full medication list for CYP3A4 and P‑gp inhibitors and adjust dose or avoid combinations where necessary.

Start at the lowest effective dose, commonly 0.6 mg daily or twice daily depending on indication and tolerance.

Monitor for gastrointestinal side effects, signs of myopathy and blood dyscrasias and provide clear missed-dose and overdose instructions with an emergency plan for severe adverse effects.

• For elderly and patients with renal or hepatic impairment, consider dose reduction or alternative therapies and specialist input.
• Document counselling and advise patients to report adverse events to Health Canada and their provincial drug plan for coverage enquiries.

Delivery Across Canada (English)

Final Practical Notes

Colchicine is most commonly supplied as 0.6 mg tablets, with capsules and an oral solution also available for those who need alternative formulations.

Always confirm the product’s DIN and check the product monograph when starting colchicine or switching brands.

Tell your pharmacist about all prescription and nonprescription medicines, supplements and herbal products to avoid dangerous interactions.

If diarrhoea or nausea starts soon after dosing, consult the dispensing pharmacist to discuss dose adjustment or alternative options.

For suspected overdose or severe adverse effects, seek immediate medical attention and inform your prescriber and provincial pharmacovigilance authority.